6-phosphogluconolactonase (PGLS) (Middle Region) Peptid
PGLS
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle PGLS Produkte
- PGLS (6-phosphogluconolactonase (PGLS))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- FPDHPLLQER EKIVAPISDS PKPPPQRVTL TLPVLNAART VIFVATGEGK
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-PGLS Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PGLS (6-phosphogluconolactonase (PGLS))
- Synonyme
- 6PGL Peptide, PGLS Peptide, PSPTO1301 Peptide, 1110030K05Rik Peptide, AI447866 Peptide, Plgs Peptide, 6-phosphogluconolactonase Peptide, PGLS Peptide, pgl Peptide, CND03390 Peptide, CNE04030 Peptide, Tb11.02.4200 Peptide, Pgls Peptide
- Hintergrund
-
Alias Symbols: 6PGL, HEL-S-304
Protein Size: 258 - Gen-ID
- 25796
- NCBI Accession
- NM_012088, NP_036220
- UniProt
- O95336
-
Sie sind hier:
